Global health R&D: What’s at stake during the 69th WHA?

GHTC Panel Discussion

May 23, 2016
Geneva, Switzerland

A lunchtime panel discussion and webinar hosted by the Global Health Technologies Coalition and the Geneva Centre for Security Policy.

This panel discussion will explore the key issues in global health R&D and offer insight on what is at stake during the 69th World Health Assembly, including ensuring sustainable R&D to support the 2030 Sustainable Development Agenda, tackling antimicrobial resistance, responding to emerging infectious diseases, and how the current WHO and UN Secretary-General processes are likely to impact R&D and innovation models.

Bernard Pécoul, Executive Director, DNDi spoke at the event.


Panel Discussion

   Joelle Tanguy, Executive in Residence, Geneva Centre for Security Policy


•    David Kaslow, Vice President of Product Development, Leader of the Center for Vaccine Innovation and Access, PATH
•    Marie-Paule Kieny, Assistant Director-General, Health Systems and Innovation, WHO
•    Suerie Moon, Research Director, Forum on Global Governance for Health, Harvard Global Health Institute
•    Ambassador Guilherme Patriota, Permanent Mission of Brazil the United Nations in Geneva (invited)
•    Bernard Pécoul, Executive Director, Drugs for Neglected Diseases initiative



More information: